Uckun, F M <br/><br/>
Effective immunochemotherapy of CALLA+C mu+ human pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19) pokeweed antiviral protein immunotoxin plus cyclophosphamide.  [electronic resource] 

 -  Blood  Jun 1992 
 - 3116-29 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--therapeutic use<br/>Antigens, CD--immunology<br/>Antigens, CD19<br/>Antigens, Differentiation, B-Lymphocyte--immunology<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Base Sequence<br/>Chromosome Aberrations<br/>Cyclophosphamide--administration & dosage<br/>DNA, Neoplasm--chemistry<br/>Humans<br/>Immunoglobulin mu-Chains--analysis<br/>Immunophenotyping<br/>Immunotoxins--therapeutic use<br/>Mice<br/>Mice, SCID<br/>Molecular Sequence Data<br/>N-Glycosyl Hydrolases<br/>Neoplasm Transplantation<br/>Plant Proteins--administration & dosage<br/>Polymerase Chain Reaction<br/>Precursor B-Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Ribosome Inactivating Proteins, Type 1